Oskar Hrnell - Bure Equity Investment Mang

BURE Stock  SEK 323.40  12.20  3.64%   

Insider

Oskar Hrnell is Investment Mang of Bure Equity AB
Age 36
Phone46 86 14 00 20
Webhttps://www.bure.se/en/home-en

Bure Equity Management Efficiency

The company has return on total asset (ROA) of (0.3716) % which means that it has lost $0.3716 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.5954) %, meaning that it generated substantial loss on money invested by shareholders. Bure Equity's management efficiency ratios could be used to measure how well Bure Equity manages its routine affairs as well as how well it operates its assets and liabilities.
The company has accumulated 2 M in total debt. Bure Equity AB has a current ratio of 23.22, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Bure Equity until it has trouble settling it off, either with new capital or with free cash flow. So, Bure Equity's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Bure Equity AB sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Bure to invest in growth at high rates of return. When we think about Bure Equity's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Gustav SamuelssonInvestment AB Latour
N/A
Lars JohanssonL E Lundbergfretagen
57
Johan SandborghL E Lundbergfretagen
44
Christina HilmerssonCreades AB
62
Sverker SivallIndustrivarden AB ser
53
B DEconL E Lundbergfretagen
71
Ivo StopnerL E Lundbergfretagen
61
Anders GustavssonIndustrivarden AB ser
42
Sofie ForsbergIndustrivarden AB ser
N/A
Jennie KnutssonIndustrivarden AB ser
47
John HedbergCreades AB
51
Katarina RautenbergInvestment AB Latour
N/A
Karl bergIndustrivarden AB ser
44
Helena StjernholmIndustrivarden AB ser
53
Lisa BirgersonCreades AB
N/A
Bjrn LenanderInvestment AB Latour
62
Anders HillerborgCreades AB
N/A
Martin KnoblochInvestment AB Latour
N/A
Fredrik MeullerInvestment AB Latour
53
Peter CFAIndustrivarden AB ser
63
Madeleine WallmarkIndustrivarden AB ser
41
Bure Equity AB is a private equity and venture capital firm specializing in secondary direct, later stage, middle market, mature, buyouts, emerging growth, expansion capital, mid venture, late venture, PIPES, bridge, industry consolidation, recapitalizations, growth capital, special situation and turnarounds. Bure Equity AB was founded on November 23, 1992 and is based in Stockholm, Sweden. Bure Equity operates under Asset Management classification in Sweden and is traded on Stockholm Stock Exchange. It employs 10 people. Bure Equity AB (BURE) is traded on Stockholm Exchange in Sweden and employs 9 people.

Management Performance

Bure Equity AB Leadership Team

Elected by the shareholders, the Bure Equity's board of directors comprises two types of representatives: Bure Equity inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Bure. The board's role is to monitor Bure Equity's management team and ensure that shareholders' interests are well served. Bure Equity's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Bure Equity's outside directors are responsible for providing unbiased perspectives on the board's policies.
Magnus Nilsson, CEO of Xvivo Perfusion
Carl Bjorkman, Independent Director
Samir Kamal, Senior Advisor
Sophie Hagstromer, Investment Director
Henrik Blomquist, CEO and President and Member of Investment Committee
Leif Thorwaldsson, CEO of PartnerTech
Gsta Johannesson, Senior Advisor
Gabriella Andersson, Investment Analyst
Charlotta Falvin, Independent Director
Elisabet Hellman, Executive Assistant
Trolle Sahlstrom, Investment Manager
Gustav Ohlsson, Advisor Bure Financial Services
Max Jonson, Chief Financial Officer
Angela Elliot, Executive Assistant
Carsten Browall, Independent Director
Eva Gidlof, Independent Director
Thomas Axelsson, CEO of Vitrolife
Sarah McPhee, Independent Director
Karl Tobieson, Chief Execute Officer of MedCap
Bengt Engstrom, Independent Director
Lena Olving, CEO of Micronic Mydata
Philip Nyblaeus, Investment Manager
Hans Biorck, Independent Director
Mathias Uhlen, Independent Director
Patrik Tigerschiold, Chairman of the Board
Oskar Hornell, Investment Manager
Ella Horvath, Investment Analyst
Fredrik Mattsson, Investment Manager
Oskar Hrnell, Investment Mang
Gosta Johannesson, Senior Advisor

Bure Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Bure Equity a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Pair Trading with Bure Equity

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bure Equity position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bure Equity will appreciate offsetting losses from the drop in the long position's value.

Moving against Bure Stock

  0.63LIPUM Lipum ABPairCorr
  0.62SCOL Scandion OncologyPairCorr
  0.62ONCO Oncopeptides ABPairCorr
The ability to find closely correlated positions to Bure Equity could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bure Equity when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bure Equity - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bure Equity AB to buy it.
The correlation of Bure Equity is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bure Equity moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bure Equity AB moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Bure Equity can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bure Equity AB. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.

Complementary Tools for Bure Stock analysis

When running Bure Equity's price analysis, check to measure Bure Equity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bure Equity is operating at the current time. Most of Bure Equity's value examination focuses on studying past and present price action to predict the probability of Bure Equity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bure Equity's price. Additionally, you may evaluate how the addition of Bure Equity to your portfolios can decrease your overall portfolio volatility.
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Fundamental Analysis
View fundamental data based on most recent published financial statements
Please note, there is a significant difference between Bure Equity's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bure Equity is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bure Equity's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.